Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New blood thinner may offer easier option for heart valve patients

NCT ID NCT07456085

First seen Mar 21, 2026 · Last updated May 24, 2026 · Updated 9 times

Summary

This study tests whether rivaroxaban, a blood thinner that doesn't need frequent blood tests, works as well as warfarin for people with mechanical heart valves. Warfarin requires regular monitoring, which can be hard in areas with limited healthcare access. Sixty adults will take either rivaroxaban or warfarin for one year, and researchers will compare rates of blood clots and bleeding. The goal is to find a safer, more convenient option for long-term blood thinning.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VALVULAR HEART DISEASE PATIENTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Rawalpindi Institute of Cardiology

    Rawalpindi, Punjab Province, 46000, Pakistan

Conditions

Explore the condition pages connected to this study.